A wide variety of viral and nonviral stimuli may induce interferon in vivo and in cell cultures. In addition, immune recognition mechanisms may be involved in production of interferon: increased interferon production has been demonstrated in cultures of sensitized cells induced with specific viral or nonviral antigens (3) (4) (5) 8) ; induction of interferon with phytohemagglutinin in cultures of human leukocytes further demonstrates the association of blastogenesis with interferon production (9) . Experiments in vivo indicate that injection of purified protein derivative (PPD) into mice infected with Mycobacterium tuberculosis strain BCG results in production of circulating interferon; uninfected mice failed to produce interferon when stimulated with PPD (7). Other experiments, using double-stranded polyinosinicpolycytidylic acid as the interferon inducer, showed an absence of correlation between immunological status and interferon induction in vivo: mice tolerant to the inducer produced normal levels of interferon, whereas interferon titers of mice immunized with the inducer were either depressed or similar to those of the control group (6) .
The purpose of this report is to examine further the role of immune recognition in the interferon response in vivo. Viral inducers, Colorado tick fever virus (CTF) and Newcastle disease virus (NDV), were used in these experiments. CTF was propagated in confluent BSC-1 cell monolayers; it had a titer of 4 x 106 plaque-forming units per ml. NDV, obtained from the University of California, Berkeley, was propagated in the allantoic cavity of chicken eggs. It had a hemagglutination titer of 640 units per ml. Immune tolerance to NDV was induced in Swiss-Webster mice (Simonsen Laboratories, Gilroy, Calif.) by injecting 70 5-weekold mice intraperitoneally with 0.5 ml of NDV per mouse on days 1, 5, and 11. This was followed on days 2, 6, and 12 by an intraperitoneal injection of 1 mg of cyclophosphamide in 0.1 ml of sterile water (Mead-Johnson Laboratories, Evansville, Ind.). On day 21, 10 mice were bled, and serum pools were prepared by using sera from five mice per pool. Sera were stored at -70 C until titrated for antibody to NDV by the hemagglutination-inhibition method (1). The remaining mice, 8 weeks old, were injected with interferon inducers and were bled at specified intervals. Mice were immunized with NDV by injecting 70 5-week-old animals intraperitoneally with 0.5 ml of NDV per mouse on days 1, 5, and 11. Bleeding of mice, antibody tests, and induction of interferon were as described above. Control groups consisted of 60 5-week-old mice injected with 1 mg of cyclophosphamide on days 2, 6, and 12 and of 60 untreated mice. To induce interferon, 1 ml of NDV or 0.5 ml of ultraviolet-irradiated CTF (2) were injected per mouse, intraperitoneally; mice were bled in groups of 10 at 3 to 4, 8, and 16 h after induction. Serum pools were prepared by using sera from five mice per pool. Sera were acidified to pH 2 with 1 N HCl and refrigerated for 4 to 5 days. After neutralization with 1 N NaOH, sera were frozen at -70 C until titrated for interferon activity by the plaque reduction method in L-929 mouse fibroblasts by using vesicular stomatitis virus as challenge. All interferon preparations were found to conform to the standard criteria established for this class of inhibitors.
Injection in the interferon response in vivo. Induction of interferon with NDV in immunized mice resulted in only slightly elevated interferon levels (Fig. 1) ; the lack of significant rise may be due to the suppressive effect of specific antibody:
antigen-antibody complexes have been reported to be poor interferon inducers (6 
